Stock listing

OTC:IRLAF IRLAB Therapeutics AB Stock

US listing (OTC) of IRLAB Therapeutics AB · home listing Stockholm:IRLABA

Follow IRLAB Therapeutics AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:IRLAB_A

1.98 SEK -0.04 (-1.9%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:IRLAB_A

Past 3 months +42.2% · daily closes, Jul 7, 2026 – Oct 19, 2026, adjusted for splits
Day range
1.93 – 2.06 SEKOct 19, 2026
Volume
935,209 sharesOct 19, 2026
Market cap
294.7M SEKAt the close on Oct 19, 2026 · price × 148.7M shares outstanding
IRLAB Therapeutics AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Frankfurt:6IRA€0.177 EUR+0.007 (+4.1%)—€0.177€0.177€0.177€0.170Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · OMXSTO:IRLAB_A · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
1.982-0.038-1.9%1.9782.061.93935,209
2.02+0.076+3.9%1.9382.061.9361,321,009
1.944+0.056+3.0%1.8881.981.801,503,904
1.888+0.018+1.0%1.911.911.804509,638
1.87+0.032+1.7%1.8121.891.812358,127
1.838+0.132+7.7%1.7421.851.701,753,182
1.706-0.114-6.3%1.7861.8361.706750,880
1.82+0.016+0.9%1.7741.8341.74628,406
1.804-0.016-0.9%1.8081.811.70347,632
1.82+0.016+0.9%1.8081.8381.776308,801
1.804-0.052-2.8%1.8181.851.778415,430
1.856+0.03+1.6%1.811.8981.776661,284
1.8260.000.0%1.8221.8481.7661,010,590
1.826-0.014-0.8%1.8481.8661.78662,220
1.84-0.046-2.4%1.8521.861.801,167,762
1.886-0.014-0.7%1.9121.9621.842587,436
1.90+0.072+3.9%1.831.9341.808919,895
1.828+0.036+2.0%1.7921.841.754817,104
1.792+0.062+3.6%1.731.8261.722789,554
1.73-0.01-0.6%1.741.7781.68526,473
1.74+0.014+0.8%1.7281.791.70238,406
1.726-0.008-0.5%1.7341.8261.692719,801
1.734-0.06-3.3%1.761.8281.718540,640
1.794-0.038-2.1%1.841.851.74468,173
1.832-0.046-2.4%1.8781.8781.79674,187
1.878+0.03+1.6%1.8461.8961.79264,183
1.848-0.05-2.6%1.8561.8741.81892,995
1.898+0.018+1.0%1.9361.9621.85928,473
1.88+0.098+5.5%1.7881.901.7641,396,457
1.782+0.056+3.2%1.751.7921.724701,646
1.726+0.016+0.9%1.711.781.686409,799
1.71-0.012-0.7%1.741.7821.692337,188
1.722-0.01-0.6%1.7321.7761.603,612,002
1.732-0.032-1.8%1.7821.7821.6941,541,865
1.764-0.028-1.6%1.8161.8161.744990,111
1.792+0.004+0.2%1.8221.831.7581,499,491
1.788+0.078+4.6%1.6981.8261.6564,292,354
1.71-0.05-2.8%1.761.781.672,352,891
1.76+0.014+0.8%1.7061.7861.6641,679,523
1.746+0.012+0.7%1.7361.761.7041,199,686
1.734+0.016+0.9%1.7181.781.704673,345
1.718+0.002+0.1%1.7181.721.69394,472
1.716+0.024+1.4%1.701.7381.682491,885
1.692-0.048-2.8%1.7441.7781.621,750,598
1.74+0.064+3.8%1.681.7481.682,546,512
1.676+0.028+1.7%1.6481.701.5942,318,081
1.648+0.028+1.7%1.6181.6581.591,337,981
1.62+0.046+2.9%1.5741.6481.5321,817,776
1.574+0.044+2.9%1.541.611.524,261,996
1.53+0.02+1.3%1.5261.5921.503,239,203
1.51-0.006-0.4%1.5541.5681.4542,238,856
1.516+0.176+13.1%1.341.5161.3083,636,833
1.34-0.018-1.3%1.361.361.316160,291
1.358+0.032+2.4%1.321.3681.302347,622
1.326+0.018+1.4%1.311.3261.3080,654
1.308-0.01-0.8%1.3121.351.30470,077
1.318+0.016+1.2%1.3021.351.276465,740
1.302-0.018-1.4%1.3181.3181.256456,510
1.32+0.088+7.1%1.2561.3281.2323,271,656
1.232-0.014-1.1%1.251.2981.23271,474
1.246-0.024-1.9%1.261.291.246447,368
1.27-0.004-0.3%1.301.3381.23395,448
1.274-0.056-4.2%1.2981.321.26236,950
1.33-0.018-1.3%1.3461.3461.2867,619
1.348+0.09+7.2%1.2581.3481.25166,477
1.258-0.03-2.3%1.291.2961.228200,290
Ticker
OTC:IRLAF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • IRLAB Therapeutics (Stockholm:IRLAB A) Q2 2026 Earnings Call

    Wed, Aug 26, 2026 · 4:00 AM ET

    Watch Transcript

  • IRLAB Therapeutics (Stockholm:IRLAB A) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 5:30 AM ET

    Watch Transcript

  • IRLAB Therapeutics (Stockholm:IRLAB A) Q2 2025 Earnings Call

    Wed, Aug 27, 2025 · 3:00 AM ET

    Watch Transcript

Latest news

IRLAB Appoints Janne Backman as New Chairman of the Board

Sep 24, 2026

Closed 1.90 (+3.9%) on Sep 25, 2026

Report from the Extraordinary General Meeting of IRLAB Therapeutics AB

Jun 5, 2026

IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)

Jan 19, 2026

IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson's Disease

Dec 23, 2025

The European Patent Office Intends to Grant a New Patent for IRLAB's Mesdopetam

Dec 11, 2025

IRLAB Appoints Gustaf Albèrt as the New Chief Financial Officer

Oct 9, 2025

IRLAB Progresses Fully Funded IRL757 Study in Parkinson's Disease in Partnership with MSRD

Oct 2, 2025

IRLAB Is Granted a Patent Strengthening the Market Exclusivity of The Drug Candidate Mesdopetam in China

Sep 4, 2025

IRLAB Appoints Roy Jonebrant as Interim CFO

Aug 21, 2025

IRLAB Reports Positive Results from the Second Part of a Phase I Study with IRL757

May 28, 2025

All IRLAB Therapeutics AB news

Decks

IRLAB Therapeutics AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 11 in all · newest Sep 24, 2026 · oldest 2025
Calls
8 calls with a replay · 8 with a transcript · latest Aug 26, 2026
Decks
20 decks · latest Oct 1, 2025

Where IRLAB Therapeutics AB is listed

ListingExchangeCountryCurrency
Stockholm:IRLABA · Home listingStockholmSwedenSEK
Aquis:IRLAASAquisUnited KingdomSEK
Aquis:IRLAASAquisUnited KingdomSEK
Frankfurt:6IRAFrankfurtGermanyEUR
OTC:IRLAF · This pageOTCUnited StatesUSD

Log in to ask 6ix AI your own questions about IRLAB Therapeutics AB.